Literature DB >> 7675953

The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.

M D Schechter1.   

Abstract

The objective of this study was to train rats to discriminate the interoceptive stimuli produced by a selective dopamine D1 agonist. Fourteen male Sprague-Dawley rats acquired the discrimination of the fully effective, high potency, D1 agonist dihydrexidine (DHX) within 20 sessions using a training dose of 3.0 mg/kg. DHX (0.75-4.5 mg/kg) dose-dependently increased DHX-appropriate responding with an ED50 = 1.44 mg/kg. The selective D1 agonist SKF 38398 (2.0-8.0 mg/kg) dose-responsively generalized with an ED50 = 3.54 mg/kg; significantly less potent than DHX. The selective D1 antagonist SCH 23390 (0.06-0.12 mg/kg) dose-responsively decreased DHX-appropriate discriminative performance. These data would indicate that DHX is a selective D1 agonist that may allow for testing of the selectivity of other putative D1 agonists in this experimental procedure. Administration of non-selective dopaminergically active drugs, including apomorphine, amphetamine and cocaine, were each shown to produce intermediate DHX-appropriate discriminative performance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675953     DOI: 10.1007/bf02246057

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.

Authors:  D A Cory-Slechta; D V Widzowski; M C Newland
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

2.  Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).

Authors:  R T Weathersby; J B Appel
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

Review 3.  Structures of dopamine receptors.

Authors:  B F O'Dowd
Journal:  J Neurochem       Date:  1993-03       Impact factor: 5.372

Review 4.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

5.  Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

Authors:  D M Mottola; W K Brewster; L L Cook; D E Nichols; R B Mailman
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

6.  Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.

Authors:  K A Cunningham; P M Callahan; J B Appel
Journal:  Eur J Pharmacol       Date:  1985-12-10       Impact factor: 4.432

7.  Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.

Authors:  J B Kamien; L I Goldberg; W L Woolverton
Journal:  J Pharmacol Exp Ther       Date:  1987-09       Impact factor: 4.030

8.  Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.

Authors:  M D Schechter; N L Greer
Journal:  Life Sci       Date:  1987-06-22       Impact factor: 5.037

9.  Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Authors:  V J Watts; C P Lawler; J H Gilmore; S B Southerland; D E Nichols; R B Mailman
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

10.  Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C.

Authors:  S A Daly; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more
  2 in total

1.  Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.

Authors:  Scott D Gleason; Jeffrey M Witkin
Journal:  Psychopharmacology (Berl)       Date:  2006-03-31       Impact factor: 4.530

2.  D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Ho-Joo Lee; Richard P Bazinet; Ruth Seemann; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.